Vivos Therapeutics (VVOS) Gross Margin (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Gross Margin of 59.5% for Q1 2026, up 947.0% year-over-year from 5.68% in Q1 2025, and down 23.85% quarter-over-quarter from 78.14% in Q4 2025.
Vivos Therapeutics (VVOS) Gross Margin (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Gross Margin for 7 consecutive years, with 59.5% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 947.0% year-over-year to 59.5%; the TTM figure through Mar 2026 stood at 61.8% (up 308.0% YoY), while the FY2025 annual figure was 60.44%, up 43.0% from the prior year.
- Gross Margin declined to 59.5% in Q1 2026 per VVOS's latest filing, from 78.14% in the prior quarter.
- Across five years, Gross Margin topped out at 78.14% in Q4 2025 and bottomed at 50.03% in Q1 2025.
- Historically, Gross Margin has averaged 60.64% across 5 years, with a median of 60.35% in 2022.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 1873 bps — and 2025, when it soared 2143 bps.
- Vivos Therapeutics' Gross Margin stood at 60.35% in 2022, then climbed by 7 bps to 64.32% in 2023, then dropped by 12 bps to 56.71% in 2024, then jumped by 38 bps to 78.14% in 2025, then retreated by 24 bps to 59.5% in 2026.
- Business Quant data shows VVOS's Gross Margin at 59.5% in Q1 2026, 78.14% in Q4 2025, and 58.04% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 45.84% |
| 10 | Vivos Therapeutics | 4.92 Mn | 3.12 Mn | 2.95 Mn | 57.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.50% |
| Dec 31, 2025 | 78.14% |
| Sep 30, 2025 | 58.04% |
| Jun 30, 2025 | 55.24% |
| Mar 31, 2025 | 50.03% |
| Dec 31, 2024 | 56.71% |
| Sep 30, 2024 | 60.47% |
| Jun 30, 2024 | 65.39% |
| Mar 31, 2024 | 56.65% |
| Dec 31, 2023 | 64.32% |
| Sep 30, 2023 | 52.92% |
| Jun 30, 2023 | 61.80% |
| Mar 31, 2023 | 60.59% |
| Dec 31, 2022 | 60.35% |
| Sep 30, 2022 | 58.78% |
| Jun 30, 2022 | 61.85% |
| Mar 31, 2022 | 70.01% |
| Dec 31, 2021 | 70.71% |
| Sep 30, 2021 | 70.02% |
| Jun 30, 2021 | 80.59% |